| 000 | 01806 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250515230649.0 | ||
| 264 | 0 | _c20100629 | |
| 008 | 201006s 0 0 eng d | ||
| 022 | _a1533-4406 | ||
| 024 | 7 |
_a10.1056/NEJMoa0909383 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMohammed, Ali Jafer | |
| 245 | 0 | 0 |
_aFractional doses of inactivated poliovirus vaccine in Oman. _h[electronic resource] |
| 260 |
_bThe New England journal of medicine _cJun 2010 |
||
| 300 |
_a2351-9 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntibodies, Viral _xbiosynthesis |
| 650 | 0 | 4 | _aDeveloping Countries |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Humoral |
| 650 | 0 | 4 | _aImmunity, Mucosal |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aInjections, Intradermal |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aInjections, Jet |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aOman |
| 650 | 0 | 4 |
_aPoliomyelitis _xprevention & control |
| 650 | 0 | 4 |
_aPoliovirus _ximmunology |
| 650 | 0 | 4 |
_aPoliovirus Vaccine, Inactivated _xadministration & dosage |
| 650 | 0 | 4 |
_aVaccination _xadverse effects |
| 700 | 1 | _aAlAwaidy, Salah | |
| 700 | 1 | _aBawikar, Shyam | |
| 700 | 1 | _aKurup, Padmamohan J | |
| 700 | 1 | _aElamir, Emadaldin | |
| 700 | 1 | _aShaban, Mahmoud M A | |
| 700 | 1 | _aSharif, Sharif M | |
| 700 | 1 | _avan der Avoort, Harrie G A M | |
| 700 | 1 | _aPallansch, Mark A | |
| 700 | 1 | _aMalankar, Pradeep | |
| 700 | 1 | _aBurton, Anthony | |
| 700 | 1 | _aSreevatsava, Meghana | |
| 700 | 1 | _aSutter, Roland W | |
| 773 | 0 |
_tThe New England journal of medicine _gvol. 362 _gno. 25 _gp. 2351-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1056/NEJMoa0909383 _zAvailable from publisher's website |
| 999 |
_c19922237 _d19922237 |
||